Henderson Brothers Financial Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$433K Sell
361
-403
-53% -$412K 0.21% 50
2026
Q1
$703K Buy
+764
New +$775K 0.18% 54
2025
Q1
$447K Buy
+416
New +$346K 0.22% 43

Other funds holding LLY

Henderson Brothers Financial Partners's LLY Position: Q2 2026 in Review

Henderson Brothers Financial Partners reduced its Eli Lilly (LLY) stake by 53% in Q2 2026, selling an estimated $412K and leaving 361 shares worth $433K. The position accounts for 0.21% of the portfolio, ranked #50.

Henderson Brothers Financial Partners first reported a position in LLY in Q1 2025 and has held it in 3 quarters since. The position peaked at $703K in Q1 2026. 4,593 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Henderson Brothers Financial Partners held 361 shares of Eli Lilly worth $433K as of Q2 2026.
  • Henderson Brothers Financial Partners sold 403 Eli Lilly shares in Q2 2026, an estimated $412K.
  • Eli Lilly made up 0.21% of Henderson Brothers Financial Partners's portfolio in Q2 2026, its #50 holding.
  • Henderson Brothers Financial Partners first reported a position in Eli Lilly in Q1 2025 and has held it in 3 quarters since.
  • Henderson Brothers Financial Partners's Eli Lilly position peaked at $703K in Q1 2026.
  • 4,593 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Henderson Brothers Financial Partners's 13F filing for Q2 2026, filed 13 Aug 2026.